Cardiome Pharma Corp (NASDAQ:CRME)
| 1.94 Data as of May 23 |  -0.06 / -3.00%Today’s Change | 1.20 Today|||52-Week Range 2.68 | +0.73% Year-to-Date |
Latest CRME News | Press Releases
No recent news for Cardiome Pharma Corp.
Today’s Trading
| Previous close | 2.00 |
| Today’s open | 2.00 |
| Day’s range | 1.94 - 2.00 |
| Volume | 53,319 |
| Average volume (3 months) | 77,449 |
| Market cap | $24.9M |
| Dividend yield | -- |
Data as of 3:59pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | +34.78% |
| Earnings growth (this year) | +80.67% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -47.57% |
| P/E ratio | -- |
| Price/Sales | 29.91 |
| Price/Book | 3.17 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ELTPElite Pharmaceutical... | -0.00 | -0.43% |
| REPCFRepliCel Life Scienc... | -0.01 | -1.85% |
| ADXSAdvaxis Inc | -0.00 | -3.37% |
| PTNPalatin Technologies... | +0.01 | +1.61% |
Data as of 3:59pm ET, 05/23/2013
Financials
| Next reporting date | August 13, 2013 |
| EPS forecast (this quarter) | -$0.15 |
| Annual revenue (last year) | $789.0K |
| Annual profit (last year) | -$18.3M |
| Net profit margin | -2,321.29% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director William L. Hunter |
Chief Operating Officer Sheila M. Grant, MBA |
Corporate headquarters Vancouver, British Columbia |
Forecasts
